<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2026-02-15)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2026-02-15)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more</h3>
<p class='source-date'><em>Endpoints News • 2026-02-14</em></p>
<p>Welcome back to Endpoints Weekly! A programming note: We won’t be sending our usual newsletters on Monday, Feb. 16. Our team will be off for Presidents’ Day. Our reporters closely followed several big updates this ...</p>
<p><a href='https://endpoints.news/moderna-vs-fda-paul-hudson-out-at-sanofi-why-clinical-trials-are-so-costly-and-more/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Pod-Based, On-Demand Media and Buffer Manufacturing System</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2026-02-13</em></p>
<p>By eliminating cold-chain transport, refrigerated storage, and excess infrastructure requirements, the Krakatoa K500 reduces supply chain risk, labor, and overall media and buffer acquisition costs while accelerating manufacturing timelines. The post Pod-Based, On-Demand Media and Buffer Manufact...</p>
<p><a href='https://www.genengnews.com/topics/bioprocessing/pod-based-on-demand-media-and-buffer-manufacturing-system/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Women in Science, Robotics, Automation, SLAS, and Lilly Updates</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2026-02-13</em></p>
<p>In this episode of GEN's Touching Base, editors discuss stories related to Women in Science Day including a synopsis of an interview with Medra’s CEO, insights from SLAS, and updates on Eli Lilly’s recent deals. The post Women in Science, Robotics, Automation, SLAS, and Lilly Updates appeared fir...</p>
<p><a href='https://www.genengnews.com/topics/artificial-intelligence/women-in-science-robotics-automation-slas-and-lilly-updates/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Antigen Orientation Boosts HPV Cancer SNA Vaccine, Slows Tumors in Models</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2026-02-13</em></p>
<p>Reorienting a single HPV antigen on a spherical nucleic acid vaccine dramatically boosted CD8⁺ T‑cell activity, slowing tumor growth in mice and patient‑derived head and neck cancer spheroids. The post Antigen Orientation Boosts HPV Cancer SNA Vaccine, Slows Tumors in Models appeared first on GEN...</p>
<p><a href='https://www.genengnews.com/topics/cancer/antigen-orientation-boosts-hpv-cancer-sna-vaccine-slows-tumors-in-models/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Will radioligand therapies keep the momentum going in 2026?</h3>
<p class='source-date'><em>Labiotech.eu • 2026-02-13</em></p>
<p>If 2025 was a consolidation year for radioligand therapies, 2026 might be about execution; delve into radiopharma 2026. The post Will radioligand therapies keep the momentum going in 2026? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this...</p>
<p><a href='https://www.labiotech.eu/in-depth/radioligand-therapy/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Using AI to crack undruggable drug targets</h3>
<p class='source-date'><em>Labiotech.eu • 2026-02-13</em></p>
<p>Today, we welcome Avital Sharir-Ivry, Co-Founder and Chief Scientific Officer of ProPhet, an Israeli startup launched from the AION Labs venture studio. The post Using AI to crack undruggable drug targets appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or dup...</p>
<p><a href='https://www.labiotech.eu/podcast/using-ai-to-crack-undruggable-drug-targets/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<div class='news-item'>
<h3>February 13, 2026</h3>
<p class='source-date'><em>Microbiome Digest – Bik's Picks • 2026-02-13</em></p>
<p>Gut microbiome Host factors dictate gut microbiome alterations in chronic kidney disease more strongly than kidney function – H. Krukowski – Nature Microbiology Baby-to-baby strain transmission shapes the developing gut microbiome – Liviana Ricci – Nature Animal Microbiome Microbiome by transcrip...</p>
<p><a href='https://microbiomedigest.com/2026/02/13/february-13-2026/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Ochrobactrum intermedium</h3>
<p class='source-date'><em>Trends in Microbiology • 2026-02-13</em></p>
<p>Ochrobactrum intermedium is a Gram-negative, rod-shaped, nonspore-forming bacterium that shows rapid colony growth on MacConkey agar (>0.5 mm after 24 h) with mucoid colony morphology and positive motility [1]. It is oxidase, urease, and catalase-positive and capable of growing at 37°C on Blood a...</p>
<p><a href='https://www.cell.com/trends/microbiology/fulltext/S0966-842X(25)00377-4?rss=yes' target='_blank'>Read more</a></p>
</div>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<div class='paper-item'>
<h4>Virulence gene profiles and antimicrobial resistance in clinical and environmental isolates of Non-O1/Non-O139 Vibrio cholerae.</h4>
<p class='source-date'><em>Zhao Ning, Weng XiaLian, Yu Yan et al. | BMC microbiology • 2026-02-14</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1186/s12866-026-04836-9' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Emergence of ceftriaxone resistant Salmonella Kentucky in India driven by multiple novel variants of Salmonella genomic island carrying bla</h4>
<p class='source-date'><em>Velmurugan Aravind, Jacob Jobin John, Solaimalai Dhanalakshmi et al. | Microbial pathogenesis • 2026-02-12</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Salmonella enterica serovar Kentucky increasingly implicated in multidrug-resistant (MDR) gastroenteritis globally. While chromosomally encoded resistance mediated by Salmonella Genomic Islands (SGIs) is well established in this serovar, recent years have seen the emergence of diverse...</p>
<p><a href='https://doi.org/10.1016/j.micpath.2026.108317' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Sources, contamination pathways, and monitoring of pathogens in urban estuaries.</h4>
<p class='source-date'><em>Hu Jingming, Zhou Yanrong, Ishii Satoshi et al. | Marine pollution bulletin • 2026-02-13</em></p>
<p><strong>Abstract:</strong> Urban estuaries are critical ecological and socio-economic interfaces but are increasingly impacted by microbial pathogen contamination driven by anthropogenic activities such as wastewater discharge, stormwater runoff, agriculture, and wildlife inputs. Despite extensive documentation of estuarin...</p>
<p><a href='https://doi.org/10.1016/j.marpolbul.2026.119415' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Benzyl isothiocyanate inhibits the conjugative transfer of mcr-1-positive plasmid via suppressing intercellular contact and limiting energy supply.</h4>
<p class='source-date'><em>Cheng Ping, Liang Shuying, Gui Shixin et al. | Journal of environmental management • 2026-02-13</em></p>
<p><strong>Abstract:</strong> The dissemination of colistin resistance has become a global health threat, increasing the ecological and human health risks. Conjugation mediated by plasmid is considered the most dominant route of colistin resistance transmission, promoting the dissemination of mcr-1 among humans, animals, wate...</p>
<p><a href='https://doi.org/10.1016/j.jenvman.2026.128976' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Rational β-turn engineering of a disulfide-free β-hairpin-like antimicrobial peptide W2PG with enhanced stability, selectivity, and in vivo efficacy.</h4>
<p class='source-date'><em>Liu Meng, Jiang Peng, Ruan Binghui et al. | Bioorganic chemistry • 2026-02-09</em></p>
<p><strong>Abstract:</strong> Antimicrobial resistance (AMR) is an increasing global concern, while the development of new antibiotics remains limited. Antimicrobial peptides (AMPs) offer an alternative due to their broad-spectrum and membrane-targeting features, but their translation is restricted by instability and cytotoxi...</p>
<p><a href='https://doi.org/10.1016/j.bioorg.2026.109612' target='_blank'>View Paper</a></p>
</div>
<h3>Synthetic & Molecular Biology Papers</h3>
<p>No recent papers on Synthetic & Molecular Biology available today.</p>
<h3>Bacteriophage Research Papers</h3>
<div class='paper-item'>
<h4>Phage therapy: innovations, challenges, and future directions in combating superbugs and antibiotic resistance.</h4>
<p class='source-date'><em>Bhale Bhushan, Shirodkar Sanket, Sawarkar Sujata et al. | Expert review of anti-infective therapy • 2026-02-13</em></p>
<p><strong>Abstract:</strong> INTRODUCTION: Antimicrobial resistance is undermining the effectiveness of conventional antibiotics and represents a critical global health challenge. This review evaluates the resurgence of bacteriophage therapy as a precision strategy to address multidrug-resistant bacterial infections. AREAS C...</p>
<p><a href='https://doi.org/10.1080/14787210.2026.2632669' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Assessing carbonylation in Pseudomonas aeruginosa clinical isolates infected by bacteriophages using flow cytometry (FCM).</h4>
<p class='source-date'><em>Yeo Jia Hao, Thong Shuhua, Chung Shimin Jasmine et al. | International journal of antimicrobial agents • 2026-02-12</em></p>
<p><strong>Abstract:</strong> OBJECTIVE: Phage therapy is emerging as alternative therapy for difficult-to-treat bacterial infections. Flow cytometry (FCM) can screen for infective phages rapidly, reducing time taken for screening infective phages to deliver a timely and effective phage-based therapy. Phage infection increase...</p>
<p><a href='https://doi.org/10.1016/j.ijantimicag.2026.107739' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>A theoretical exploration of protocols for treating prosthetic joint infections with combinations of antibiotics and bacteriophage.</h4>
<p class='source-date'><em>Levin Bruce R, Gil-Gil Teresa, Berryhill Brandon A et al. | NPJ biofilms and microbiomes • 2026-02-14</em></p>
<p><strong>Abstract:</strong> With the increase in the placement of prosthetic joints and other hardware in the body, associated infections have risen. These infections are complicated to treat due to the underlying bacteria generating matrices that resist clearance by immune system effectors or antibiotics. These matrices, b...</p>
<p><a href='https://doi.org/10.1038/s41522-025-00908-2' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Realizing phage therapy in the UK.</h4>
<p class='source-date'><em>Brockhurst Michael A, Fothergill Joanne L, van Houte Stineke et al. | Nature microbiology • 2026-02-13</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1038/s41564-026-02280-z' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Immune responses to phage therapy in humans: A review.</h4>
<p class='source-date'><em>Bosco Kiran, Fabijan Aleksandra Petrovic, Iredell Jonathan et al. | The Journal of infectious diseases • 2026-02-13</em></p>
<p><strong>Abstract:</strong> This review explores mammalian immune responses to phages with a particular emphasis on human immune responses to therapeutic phages and their potential implications for the outcomes of phage therapy. Despite the ubiquity of phages in the human microbiome, particularly in the gut (the phageome), ...</p>
<p><a href='https://doi.org/10.1093/infdis/jiag096' target='_blank'>View Paper</a></p>
</div>
<h3>Skin Microbiome & Disease Papers</h3>
<p>No recent papers on Skin Microbiome & Disease available today.</p>
<hr>
<p><em>Report generated on 2026-02-15</em></p>
</div>
</body>
</html>